Treat COPD and asthma as an air-pollution disease: pair clinical care with exposure control

Diagnosis

Chronic obstructive pulmonary disease and asthma are classed here as a structural, regime-level non-communicable disease burden, and the curated characterization is explicit about the driver: this caseload is linked to chronic air-pollution exposure. That framing matters for who owns the problem. A condition produced by sustained exposure to polluted air cannot be solved inside the consultation room alone. If the health system treats COPD and asthma only as a clinical caseload (inhalers dispensed, exacerbations admitted), it manages symptoms while the underlying exposure that generates new cases continues unchecked.

The lead responsible body is the Directorate General of Health Services (DGHS), with the Department of Public Health Engineering (DPHE) named as the supporting body. That pairing is the policy signal: the exposure side (ambient and household air quality, including the engineering of cleaner cooking, ventilation, and water-and-sanitation adjacent infrastructure that DPHE controls) has to move in step with the treatment side that DGHS controls. The current_state indicator is not populated in the grounded context, so this brief does not assert a prevalence or trend figure. The decision-relevant fact is the causal link itself, and it points to a two-track response.

Recommended actions

1. Stand up a national COPD and asthma management protocol inside primary care. Owner: DGHS. Mechanism: a clinical directive and standard treatment guideline routed through upazila health complexes and community clinics, with a standing supply line for essential inhaled medicines. Observable signal: a rising share of upazila facilities reporting protocol adoption and uninterrupted inhaler stock.
2. Define COPD and asthma as exposure-linked conditions in surveillance. Owner: DGHS. Mechanism: add a chronic respiratory module to the existing NCD reporting flow so that diagnosed cases are recorded by facility and area, giving the first real denominator. Observable signal: routine facility returns that include respiratory case counts, enabling the currently empty current_state indicator to be filled with real data.
3. Open a formal DGHS to DPHE referral and exposure-reduction channel. Owner: DGHS with DPHE as supporting body. Mechanism: a joint memorandum that lets clinical hotspots (areas with concentrated case loads) trigger DPHE-led exposure interventions such as cleaner household cooking and ventilation improvements. Observable signal: a documented set of exposure interventions initiated in clinically flagged areas.
4. Train and equip frontline providers for spirometry-light triage. Owner: DGHS. Mechanism: a programme budget line for peak-flow and basic diagnostic tooling plus provider training, so cases are caught and graded rather than mislabeled. Observable signal: an increase in formally diagnosed (not just symptomatically treated) patients.

Sequencing (first 12 months)

Start with action 2, surveillance, because nothing else can be targeted without a denominator. Once cases are recorded by area, action 1 (the management protocol) gives those patients a defined standard of care, and the hotspot map from surveillance is what unlocks action 3, the DPHE referral channel: you cannot direct exposure-reduction effort until you know where the disease concentrates. Action 4, diagnostic tooling, runs in parallel and feeds cleaner data back into surveillance.

Risks and constraints

The binding constraint is institutional, not clinical. The disease driver (air pollution) sits largely outside DGHS authority, so DGHS can manage cases but cannot by itself remove the exposure. Without a working DGHS to DPHE channel, the brief reduces to symptom management. Fiscally, sustaining an uninterrupted essential-medicine supply line and diagnostic tooling at upazila level is a recurring cost, and chronic-disease programmes compete poorly against acute and communicable priorities for budget attention. The empty current_state indicator is itself a risk: without a baseline, neither progress nor failure can be demonstrated to the bodies that fund the response.

Bottom line

COPD and asthma here are an air-pollution disease, so DGHS should build surveillance and a primary-care protocol while opening a standing referral channel to DPHE to attack the exposure that generates new cases. Treating it as a clinical caseload alone manages symptoms while the cause keeps producing patients.